Galson Steven K bought BCRX
May 13, 2024 · Form 4 insider transaction
Galson Steven K bought 21,940 shares of BioCryst Pharmaceuticals, Inc. at $5.49 per share, a transaction worth $120.5K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
21,940
Price
$5.49
Total value
$120.5K
InsiderGalson Steven K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 13, 2024
Filing dateMay 15, 2024
Shares owned after51,551
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $5.48 to $5.49. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.